A publication by Dina Baier et al. explores the novel mode of action of the ruthenium-based compound BOLD-100 and mechanisms underlying acquired...
A team of scientists from the Institute of Inorganic Chemistry recently published an perspective article in Inorg. Chem. Frontiers, describing the...
Markus Mitterhauser from the Vienna Medical University joins the Radiochemistry Group.
Sophia Harringer wins Award of Excellence 2021
Success for the Environmental Chemistry Group at PTIM 2021 conference
The ruthenium-based anticancer agent BOLD-100 just received an Orphan Drug Designation in the treatment of gastric (stomach) cancer from the U.S. Food...
